ArticleFrontiers in immunology2025

Hepatic arterial interventional therapies alone or in combination with molecular targeted therapies and PD-(L)1 inhibitors in locally aggressive, early recurrent hepatocellular carcinoma: a retrospective study.

Weixin Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.